Thalassaemia trials in Saudi Arabia
3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Where
- Jizan, Riyadh
- Age
- 2 years and over
- People
- 480 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06609226 · EU 2024-510805-27-00 - No phaseTaking peopleA Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East
- Where
- Al Hofuf and Al Mubarraz, Al Qaţīf, Dammam, Jizan, Mecca, Riyadh
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07215975 - Phase 3Taking peopleEvaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- Where
- Al Mathar Ash Shamali
- Age
- 12 years to 35 years
- People
- 26 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT05477563 · EU 2024-514641-12-00